Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 275


Understanding Heroin Overdose: A Study of the Acute Respiratory Depressant Effects of Injected Pharmaceutical Heroin.

Jolley CJ, Bell J, Rafferty GF, Moxham J, Strang J.

PLoS One. 2015 Oct 23;10(10):e0140995. doi: 10.1371/journal.pone.0140995. eCollection 2015. Erratum in: PLoS One. 2015;10(11):e0143672.


Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Martins SS, Sampson L, Cerdá M, Galea S.

Am J Public Health. 2015 Nov;105(11):e29-49. doi: 10.2105/AJPH.2015.302843.


Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Martins SS, Sampson L, Cerdá M, Galea S.

Am J Public Health. 2015 Nov;105(11):2373. doi: 10.2105/AJPH.2015.302843a.


Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study.

Kaplovitch E, Gomes T, Camacho X, Dhalla IA, Mamdani MM, Juurlink DN.

PLoS One. 2015 Aug 20;10(8):e0134550. doi: 10.1371/journal.pone.0134550. eCollection 2015.


Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Green TC, Dauria EF, Bratberg J, Davis CS, Walley AY.

Harm Reduct J. 2015 Aug 6;12:25. doi: 10.1186/s12954-015-0058-x.


Development of an algorithm to identify serious opioid toxicity in children.

Chung CP, Callahan ST, Cooper WO, Murray KT, Hall K, Dudley JA, Stein CM, Ray WA.

BMC Res Notes. 2015 Jul 4;8:293. doi: 10.1186/s13104-015-1185-x.


Messaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey Experiment.

Bachhuber MA, McGinty EE, Kennedy-Hendricks A, Niederdeppe J, Barry CL.

PLoS One. 2015 Jul 1;10(7):e0130050. doi: 10.1371/journal.pone.0130050. eCollection 2015.


Asystolic Cardiac Arrest of Unknown Duration in Profound Hypothermia and Polysubstance Overdose: A Case Report of Complete Recovery.

Lubana SS, Genin DI, Singh N, De La Cruz A.

Am J Case Rep. 2015 Jun 8;16:353-6. doi: 10.12659/AJCR.893880.


Buprenorphine treatment for narcotic addiction: not without risks.

Sansone RA, Sansone LA.

Innov Clin Neurosci. 2015 Mar-Apr;12(3-4):32-6.


A social gradient in fatal opioids and cocaine related overdoses?

Origer A, Le Bihan E, Baumann M.

PLoS One. 2015 May 4;10(5):e0125568. doi: 10.1371/journal.pone.0125568. eCollection 2015.


Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.

Molfenter T, Sherbeck C, Zehner M, Quanbeck A, McCarty D, Kim JS, Starr S.

Subst Abuse Treat Prev Policy. 2015 Mar 28;10:13. doi: 10.1186/s13011-015-0009-2.


Prescription practices involving opioid analgesics among Americans with Medicaid, 2010.

Mack KA, Zhang K, Paulozzi L, Jones C.

J Health Care Poor Underserved. 2015 Feb;26(1):182-98. doi: 10.1353/hpu.2015.0009.


Polysubstance abuse: alcohol, opioids and benzodiazepines require coordinated engagement by society, patients, and physicians.

Ogbu UC, Lotfipour S, Chakravarthy B.

West J Emerg Med. 2015 Jan;16(1):76-9. doi: 10.5811/westjem.2014.11.24720. Epub 2014 Dec 15.


Prescription drug monitoring programs: examining limitations and future approaches.

Griggs CA, Weiner SG, Feldman JA.

West J Emerg Med. 2015 Jan;16(1):67-70. doi: 10.5811/westjem.2014.10.24197. Epub 2015 Jan 6.


Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Wermeling DP.

Ther Adv Drug Saf. 2015 Feb;6(1):20-31. doi: 10.1177/2042098614564776. Review.


Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Lee J, Kresina TF, Campopiano M, Lubran R, Clark HW.

Biomed Res Int. 2015;2015:137020. doi: 10.1155/2015/137020. Epub 2015 Jan 5. Review.


Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling.

Corrigan F, Wu Y, Tuke J, Coller JK, Rice KC, Diener KR, Hayball JD, Watkins LR, Somogyi AA, Hutchinson MR.

Brain Behav Immun. 2015 Mar;45:245-52. doi: 10.1016/j.bbi.2014.12.019. Epub 2014 Dec 24.


Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.

Gomes T, Juurlink D, Yao Z, Camacho X, Paterson JM, Singh S, Dhalla I, Sproule B, Mamdani M.

CMAJ Open. 2014 Oct 1;2(4):E256-61. doi: 10.9778/cmajo.20140027. eCollection 2014 Oct.


Harms of prescription opioid use in the United States.

Imtiaz S, Shield KD, Fischer B, Rehm J.

Subst Abuse Treat Prev Policy. 2014 Oct 27;9:43. doi: 10.1186/1747-597X-9-43.


Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.

Roth AM, Armenta RA, Wagner KD, Roesch SC, Bluthenthal RN, Cuevas-Mota J, Garfein RS.

Subst Use Misuse. 2015 Jan;50(2):205-14. doi: 10.3109/10826084.2014.962661. Epub 2014 Oct 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk